| 冠心病阿替洛尔干预前后QT离散度的变化 |
| |
| 引用本文： | 裴旭东,樊晓霞,郭志昌.冠心病阿替洛尔干预前后QT离散度的变化[J].航空航天医药,2001,12(2):72-73. |
| |
| 作者姓名： | 裴旭东 樊晓霞 郭志昌 |
| |
| 作者单位： | 太原航空仪表有限公司职工医院 |
| |
| 摘 要： | 目的：探讨β受体阻滞剂对冠心病患者QT离散度的影响。方法：对照组常规抗心肌缺血治疗，实验组常规抗心肌缺血治疗加用阿替洛尔。结果：实验组治疗后QTmax无改变（P＞0．05），心率显著减慢（P＜0．01），QTmin延长（P＜0．01），QTd、QTcd缩小（P＜0．05）。结论：β受体阻滞剂可缩小冠心病患者QT离散度，有效降低其猝死率。
|
| 关 键 词： | 冠心病 β受体阻滞剂 QT离散度 阿替洛尔 |
| 文章编号： | 1005-9334(2001)02-072-02 |
| 修稿时间： | 2000年7月1日 |
Change of QT-dispersion whead and after interference by Atenolol in coronary heart disease. |
| |
| Peix-udong,Fanxiaoxia,Guozhichang.Change of QT-dispersion whead and after interference by Atenolol in coronary heart disease.[J].Aerospace Medicine,2001,12(2):72-73. |
| |
| Authors: | Peix-udong Fanxiaoxia Guozhichang |
| |
| Abstract: | OBJECTIVE: To investigate the effects of β-receptor blocking drugs on QT-dispersion on patients with coronary
heart disease. METKODS: Contrd group was treated by routine antiischemia methed, experimental group was treated by rou
tine method and added Atenolol. RESULTS: After treatment, in experimental groups, QTmax didn' t change(P> 0.05), rate
of heart lowered obviously (P< 0.01), QTmin prolonged (P< 0.01), QTd and QTcd lessened (P< 0.05). CONCLUSION: β-receptor blocking drugs can reduce QT-dispersion in patients with coronary hear disease and reduce the rate of sudden death ef fectively. |
| |
| Keywords: | |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
